APOE ε4 stratification confirmed the high prevalence of GSTO1*A140 as all 16 APOE ε4-negative AD patients exhibited the GSTO1*A140A genotype (vs. 25 % of APOE ε4-negative controls). The gene discussed is GSTO1; the disease is Alzheimer disease.